Tvardi Therapeutics, Inc. (TVRD) support and resistance · rev $2.6M
Tvardi Therapeutics, Inc. (TVRD) is a biotechnology company listed on US.
This page maps Tvardi Therapeutics, Inc. (TVRD) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported TVRD revenue for 2025-03-31 was $2.6M. Net income was -$4.9M. TVRD currently screens at market cap $0.
TVRD currently screens at market cap $0. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new TVRD 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the TVRD quote page for the session range and the stock page for the full model.
Not investment advice.